Correlation between different levels and patterns of dyslipidemia and glomerular filtration rate in patients with type 2 diabetes: A cross‐sectional survey of a regional cohort
Journal of Clinical Laboratory Analysis · 2023
DOI: 10.1002/jcla.24954 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2023. Verfasst von Amirhossein Yadegar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic, Dyslipidemias. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Due to the high cardiovascular risk in patients with diabetic nephropathy, more attention should be paid to lipid levels and dyslipidemia in these patients. The current study investigated the association between single and mixed dyslipidemia patterns, estimated glomerular filtration rate (eGFR), and different chronic kidney disease (CKD) stages.
Methods
This cross‐sectional study evaluated 4059 patients with type 2 diabetes (T2D). TG, TC, LDL‐C, and HDL‐C were measured. Non‐HDL‐C and AIP were calculated. We estimated eGFR using the CKD‐EPI equation.
Results
With the progression of the kidney failure stage, mean levels of TG, LDL‐C, non‐HDL‐C, and AIP decreased. HDL‐C levels decreased with the advance of the CKD stage in men but did not change significantly in women. The prevalence of single dyslipidemia, including high LDL‐C and high non‐HDL‐C, decreased with the advancing CKD stage. The prevalence of mixed dyslipidemia patterns, including high AIP and high LDL‐C, high AIP and high non‐HDL‐C, showed a significant downward tendency. TG and AIP levels were negatively, and HDL‐C levels were positively correlated with eGFR after adjusting for the risk factors. Also, CKD stage 3 was positively related to the risk of high TG and low HDL‐C.
Conclusion
This study shows that blood lipids decreased with the progression of renal failure in patients with T2D. However, after adjustment, TG and AIP levels had negative, and HDL‐C levels had a positive correlation with eGFR, which could be consistent with the hypothesis that eGFR decreases with increasing TG or AIP levels or decreasing HDL‐C levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Research Center for Advanced Technologies in Cardiovascular Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Manouchehr Nakhjavani
Zitieren
APA
Yadegar, A., Mohammadi, F., Rabizadeh, S., Ayati, A., Seyedi, S. A., Nabipoorashrafi, S. A., Esteghamati, A., & Nakhjavani, M. (2023). Correlation between different levels and patterns of dyslipidemia and glomerular filtration rate in patients with type 2 diabetes: A cross‐sectional survey of a regional cohort. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.24954
Vancouver
Yadegar A, Mohammadi F, Rabizadeh S, Ayati A, Seyedi SA, Nabipoorashrafi SA, et al. Correlation between different levels and patterns of dyslipidemia and glomerular filtration rate in patients with type 2 diabetes: A cross‐sectional survey of a regional cohort. Journal of Clinical Laboratory Analysis. 2023. doi:10.1002/jcla.24954
BibTeX
@article{Yadegar2023,
author = {Yadegar, Amirhossein and Mohammadi, Fatemeh and Rabizadeh, Soghra and Ayati, Aryan and Seyedi, Seyed Arsalan and Nabipoorashrafi, Seyed Ali and Esteghamati, Alireza and Nakhjavani, Manouchehr},
title = {Correlation between different levels and patterns of dyslipidemia and glomerular filtration rate in patients with type 2 diabetes: A cross‐sectional survey of a regional cohort},
journal = {Journal of Clinical Laboratory Analysis},
year = {2023},
doi = {10.1002/jcla.24954}
}
EUVIMED